Sunesis to Host Conference Call on March 10th to Discuss Fourth Quarter and Full-Year 2015 Financial Results and Recent Highl...
March 09 2016 - 7:46PM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it
will host a conference call on Thursday, March 10, 2016 at 11:00
a.m. Eastern Time to discuss corporate updates and financial
results for the fourth quarter and year ended December 31, 2015.
The call can be accessed by dialing (877) 771-6242
(U.S. and Canada) or (440) 996-5676 (international), and entering
passcode 49218884.
To access the live audio webcast, or the subsequent
archived recording, visit the "Investors and Media - Calendar of
Events" section of the Sunesis website at www.sunesis.com. The
webcast will be recorded and available for replay on the company's
website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on
the development and commercialization of new oncology therapeutics
for the potential treatment of solid and hematologic cancers.
Sunesis has built a highly experienced cancer drug development
organization committed to improving the lives of people with cancer
and is currently pursuing regulatory approval in Europe for its
lead product candidate, vosaroxin, for the treatment of relapsed or
refractory acute myeloid leukemia in patients aged 60 and older. In
addition, the company is advancing its kinase-inhibitor pipeline of
novel targeted therapies into the clinic.
For additional information on Sunesis, please
visit http://www.sunesis.com.
SUNESIS and the logos are trademarks
of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2023 to Aug 2024